Skip to main content
SpringerLink
Log in

Thyroid and Parathyroid Imaging

  • Chapter
  • First Online:
Clinical Nuclear Medicine

  • 1469 Accesses

Abstract

For over 70 years, the history of nuclear medicine has been closely intertwined with the use of iodine in the diagnosis and therapy of thyroid disorders, one of the few medical procedures that have stood this extensive test of time. Technetium-based methods of parathyroid imaging emerged in the 1970s and remain a mainstay of diagnosis until the present. The current chapter explores the background and use of these techniques in the current era.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Chiamolera MI, Wondisford FE. Minireview: thyrotropin-releasing hormone and the thyroid hormone feedback mechanism. Endocrinology. 2009;150(3):1091–6. https://doi.org/10.1210/en.2008-1795.

    Article  CAS  PubMed  Google Scholar 

  2. Dietrich JW, Landgrafe G, Fotiadou EH. TSH and thyrotropic agonists: key actors in thyroid homeostasis. J Thyroid Res. 2012;2012:351864. https://doi.org/10.1155/2012/351864.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Ozgur Z, Celik S, Govsa F, Ozgur T. Anatomical and surgical aspects of the lobes of the thyroid glands. Eur Arch Otorhinolaryngol. 2011;268(9):1357–63. https://doi.org/10.1007/s00405-011-1502-5.

    Article  PubMed  Google Scholar 

  4. Pankow BG, Michalak J, McGee MK. Adult human thyroid weight. Health Phys. 1985;49(6):1097–103.

    Article  CAS  PubMed  Google Scholar 

  5. Braun EM, Windisch G, Wolf G, Hausleitner L, Anderhuber F. The pyramidal lobe: clinical anatomy and its importance in thyroid surgery. Surg Radiol Anat. 2007;29(1):21–7. https://doi.org/10.1007/s00276-006-0165-1.

    Article  PubMed  Google Scholar 

  6. Policeni BA, Smoker WR, Reede DL. Anatomy and embryology of the thyroid and parathyroid glands. Semin Ultrasound CT MR. 2012;33(2):104–14. https://doi.org/10.1053/j.sult.2011.12.005.

    Article  PubMed  Google Scholar 

  7. Rohner F, Zimmermann M, Jooste P, Pandav C, Caldwell K, Raghavan R, Raiten DJ. Biomarkers of nutrition for development—iodine review. J Nutr. 2014;144(8):1322S–42S. https://doi.org/10.3945/jn.113.181974.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Li JH, He ZH, Bansal V, Hennessey JV. Low iodine diet in differentiated thyroid cancer: a review. Clin Endocrinol. 2016;84(1):3–12. https://doi.org/10.1111/cen.12846.

    Article  CAS  Google Scholar 

  9. Pretell, E. A., Pearce, E. N., Moreno, S. A., Dary, O., Kupka, R., Gizak, M., . . . Zimmermann, M. B. (2017). Elimination of iodine deficiency disorders from the Americas: a public health triumph. Lancet Diabetes Endocrinol, 5(6), 412–414. https://doi.org/10.1016/S2213-8587(17)30034-7.

    Article  PubMed  Google Scholar 

  10. Dohan O, Portulano C, Basquin C, Reyna-Neyra A, Amzel LM, Carrasco N. The Na+/I symporter (NIS) mediates electroneutral active transport of the environmental pollutant perchlorate. Proc Natl Acad Sci U S A. 2007;104(51):20250–5. https://doi.org/10.1073/pnas.0707207104.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Portulano C, Paroder-Belenitsky M, Carrasco N. The Na+/I-symporter (NIS): mechanism and medical impact. Endocr Rev. 2014;35(1):106–49. https://doi.org/10.1210/er.2012-1036.

    Article  CAS  PubMed  Google Scholar 

  12. Zuckier LS, Dohan O, Li Y, Chang CJ, Carrasco N, Dadachova E. Kinetics of perrhenate uptake and comparative biodistribution of perrhenate, pertechnetate, and iodide by NaI symporter-expressing tissues in vivo. J Nucl Med. 2004;45(3):500–7.

    CAS  PubMed  Google Scholar 

  13. Pittman CS, Chambers JB Jr, Read VH. The extrathyroidal conversion rate of thyroxine to triiodothyronine in normal man. J Clin Invest. 1971;50(6):1187–96. https://doi.org/10.1172/JCI106596.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Maia AL, Kim BW, Huang SA, Harney JW, Larsen PR. Type 2 iodothyronine deiodinase is the major source of plasma T3 in euthyroid humans. J Clin Invest. 2005;115(9):2524–33. https://doi.org/10.1172/JCI25083.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Rousset B, Dupuy C, Miot F. Thyroid hormone synthesis and secretion. In: De Groot CG, Dungan K, et al., editors. Endotext. South Dartmouth, MA: MDText.com, Inc; 2015.

    Google Scholar 

  16. van der Spek, A. H., Fliers, E., & Boelen, A. (2017). The classic pathways of thyroid hormone metabolism. Mol Cell Endocrinol 458 29. https://doi.org/10.1016/j.mce.2017.01.025

    Article  CAS  PubMed  Google Scholar 

  17. Balon, H. R., Silberstein, E. B., Meier, D. A., Charkes, D., Sarkar, S., Royal, H., & Donohoe, K. (2006). Society of nuclear medicine procedure guideline for thyroid scintigraphy, version 3.0. 2006. http://interactive.snm.org/index.cfm?PageID=772.

  18. Parsa AA, Gharib H. History and examination for thyroid nodules. In: Gharib H, editor. Thyroid nodules. Contemporary endocrinology. Cham: Humana; 2018.

    Google Scholar 

  19. Mandel SJ, Shankar LK, Benard F, Yamamoto A, Alavi A. Superiority of iodine-123 compared with iodine-131 scanning for thyroid remnants in patients with differentiated thyroid cancer. Clin Nucl Med. 2001;26(1):6–9.

    Article  CAS  PubMed  Google Scholar 

  20. Pentlow, K. S., Graham, M. C., Lambrecht, R. M., Daghighian, F., Bacharach, S. L., Bendriem, B., . . . Larson, S. M. (1996). Quantitative imaging of iodine-124 with PET. J Nucl Med, 37(9), 1557–1562.

    CAS  PubMed  Google Scholar 

  21. Meller J, Becker W. The continuing importance of thyroid scintigraphy in the era of high-resolution ultrasound. Eur J Nucl Med Mol Imaging. 2002;29(Suppl 2):S425–38. https://doi.org/10.1007/s00259-002-0811-8.

    Article  PubMed  Google Scholar 

  22. Liu Y. Clinical significance of thyroid uptake on F18-fluorodeoxyglucose positron emission tomography. Ann Nucl Med. 2009;23(1):17–23. https://doi.org/10.1007/s12149-008-0198-0.

    Article  CAS  PubMed  Google Scholar 

  23. Bae JS, Chae BJ, Park WC, Kim JS, Kim SH, Jung SS, Song BJ. Incidental thyroid lesions detected by FDG-PET/CT: prevalence and risk of thyroid cancer. World J Surg Oncol. 2009;7:63. https://doi.org/10.1186/1477-7819-7-63.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Greenspan, B. S., Dillehay, G., Intenzo, C., Lavely, W. C., O'Doherty, M., Palestro, C. J., . . . Tulchinsky, M. (2012). SNM practice guideline for parathyroid scintigraphy 4.0. J Nucl Med Technol, 40(2), 111–118. https://doi.org/10.2967/jnmt.112.105122.

    Article  PubMed  Google Scholar 

  25. Becker, D., Charles, N. D., Dworkin, H., Hurley, J., McDougall, I. R., Price, D., . . . Sarkar, S. (1996). Procedure guideline for thyroid scintigraphy: 1.0 Society of Nuclear MedicineJ Nucl Med, 37(7), 1264–1266.

    CAS  PubMed  Google Scholar 

  26. National Institutes of Health. Patient education – procedures/diagnostic tests – thyroid scan/thyroid uptake study. Bethesda, MD: National Institutes of Health; 2000. https://www.cc.nih.gov/ccc/patient_education/procdiag/thyroidupt.pdf

    Google Scholar 

  27. Gregory, R. A., Murray, I., Gear, J., Aldridge, M. D., Levine, D., Fowkes, L., . . . Flux, G. (2017). Objective comparison of lesion detectability in low and medium-energy collimator iodine-123 mIBG images using a channelized Hotelling observer. Phys Med Biol, 62(1), 17–30. https://doi.org/10.1088/1361-6560/62/1/17.

    Article  CAS  PubMed  Google Scholar 

  28. Macey DJ, DeNardo GL, DeNardo SJ, Hines HH. Comparison of low- and medium-energy collimators for SPECT imaging with iodine-123-labeled antibodies. J Nucl Med. 1986;27(9):1467–74.

    CAS  PubMed  Google Scholar 

  29. Pelletier-Galarneau M, Sogbein O, Zeng W, Zuckier L. Count rate of 99mTc-pertechnetate thyroid imaging can be used as a surrogate of 24 hour 131I radioactive iodide uptake (RAIU) in a clinically meaningful manner. Paper presented at the European Journal of Nuclear Medicine and Molecular Imaging. 2013.

    Google Scholar 

  30. Higgins HP, Ball D, Eastham S. 20-min 99mTc thyroid uptake: a simplified method using the gamma camera. J Nucl Med. 1973;14(12):907–11.

    CAS  PubMed  Google Scholar 

  31. Pelletier-Galarneau M, Martineau P, Klein R, Henderson M, Zuckier LS. Reproducibility of radioactive iodine uptake (RAIU) measurements. J Appl Clin Med Phys. 2018;19(1):239–42. https://doi.org/10.1002/acm2.12217.

    Article  PubMed  Google Scholar 

  32. Balon HR, Silberstein EB, Meier DA, Charkes D, Royal H, Sarkar S, Donohoe K. Society of nuclear medicine procedure guideline for thyroid uptake measurement, version 3.0; 2006. http://interactive.snm.org/index.cfm?PageID=772.

  33. Wong ET, Schultz AL. Changing values for the normal thyroid radioactive iodine uptake test. JAMA. 1977;238(16):1741–3.

    Article  CAS  PubMed  Google Scholar 

  34. Wolff J, Chaikoff IL, et al. The temporary nature of the inhibitory action of excess iodine on organic iodine synthesis in the normal thyroid. Endocrinology. 1949;45(5):504–13. https://doi.org/10.1210/endo-45-5-504.

    Article  CAS  PubMed  Google Scholar 

  35. Noussios G, Anagnostis P, Goulis DG, Lappas D, Natsis K. Ectopic thyroid tissue: anatomical, clinical, and surgical implications of a rare entity. Eur J Endocrinol. 2011;165(3):375–82. https://doi.org/10.1530/EJE-11-0461.

    Article  CAS  PubMed  Google Scholar 

  36. Dussault JH, Coulombe P, Laberge C, Letarte J, Guyda H, Khoury K. Preliminary report on a mass screening program for neonatal hypothyroidism. J Pediatr. 1975;86(5):670–4.

    Article  CAS  PubMed  Google Scholar 

  37. Dussault JH, Laberge C. Thyroxine (T4) determination by radioimmunological method in dried blood eluate: new diagnostic method of neonatal hypothyroidism? Union Med Can. 1973;102(10):2062–4.

    CAS  PubMed  Google Scholar 

  38. Dussault JH. The anecdotal history of screening for congenital hypothyroidism. J Clin Endocrinol Metab. 1999;84(12):4332–4. https://doi.org/10.1210/jcem.84.12.6221.

    Article  CAS  PubMed  Google Scholar 

  39. Rastogi MV, LaFranchi SH. Congenital hypothyroidism. Orphanet J Rare Dis. 2010;5:17. https://doi.org/10.1186/1750-1172-5-17.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Canaris GJ, Manowitz NR, Mayor G, Ridgway EC. The Colorado thyroid disease prevalence study. Arch Intern Med. 2000;160(4):526–34.

    Article  CAS  PubMed  Google Scholar 

  41. Franklyn JA. The thyroid—too much and too little across the ages. The consequences of subclinical thyroid dysfunction. Clin Endocrinol. 2013;78(1):1–8. https://doi.org/10.1111/cen.12011.

    Article  CAS  Google Scholar 

  42. Leung AM, Braverman LE. Consequences of excess iodine. Nat Rev Endocrinol. 2014;10(3):136–42. https://doi.org/10.1038/nrendo.2013.251.

    Article  CAS  PubMed  Google Scholar 

  43. Grammaticos P, Vasiliou O, Papanastasiou E, Gerasimou G, Balaris V, Alexandris R, et al. The clinical and laboratory findings in Graves’ multinodular type disease. Hell J Nucl Med. 2006;9(1):53–9.

    PubMed  Google Scholar 

  44. Charkes ND. Graves’ disease with functioning nodules (Marine-Lenhart syndrome). J Nucl Med. 1972;13(12):885–92.

    CAS  PubMed  Google Scholar 

  45. Torring O, Tallstedt L, Wallin G, Lundell G, Ljunggren JG, Taube A, et al. Graves’ hyperthyroidism: treatment with antithyroid drugs, surgery, or radioiodine—a prospective, randomized study. Thyroid Study Group. J Clin Endocrinol Metab. 1996;81(8):2986–93. https://doi.org/10.1210/jcem.81.8.8768863.

    Article  CAS  PubMed  Google Scholar 

  46. Dean DS, Gharib H. Epidemiology of thyroid nodules. Best Pract Res Clin Endocrinol Metab. 2008;22(6):901–11. https://doi.org/10.1016/j.beem.2008.09.019.

    Article  PubMed  Google Scholar 

  47. Haugen, B. R., Alexander, E. K., Bible, K. C., Doherty, G. M., Mandel, S. J., Nikiforov, Y. E., . . . Wartofsky, L. (2016). 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid Cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid Cancer. Thyroid, 26(1), 1–133. https://doi.org/10.1089/thy.2015.0020.

    Article  PubMed  PubMed Central  Google Scholar 

  48. Giuffrida D, Gharib H. Controversies in the management of cold, hot, and occult thyroid nodules. Am J Med. 1995;99(6):642–50.

    Article  CAS  PubMed  Google Scholar 

  49. McCall A, Jarosz H, Lawrence AM, Paloyan E. The incidence of thyroid carcinoma in solitary cold nodules and in multinodular goiters. Surgery. 1986;100(6):1128–32.

    CAS  PubMed  Google Scholar 

  50. Kusic Z, Becker DV, Saenger EL, Paras P, Gartside P, Wessler T, Spaventi S. Comparison of technetium-99m and iodine-123 imaging of thyroid nodules: correlation with pathologic findings. J Nucl Med. 1990;31(4):393–9.

    CAS  PubMed  Google Scholar 

  51. Pearce EN, Farwell AP, Braverman LE. Thyroiditis. N Engl J Med. 2003;348(26):2646–55. https://doi.org/10.1056/NEJMra021194.

    Article  PubMed  Google Scholar 

  52. Epstein AE, Olshansky B, Naccarelli GV, Kennedy JI Jr, Murphy EJ, Goldschlager N. Practical management guide for clinicians who treat patients with amiodarone. Am J Med. 2016;129(5):468–75. https://doi.org/10.1016/j.amjmed.2015.08.039.

    Article  PubMed  Google Scholar 

  53. Tsang W, Houlden RL. Amiodarone-induced thyrotoxicosis: a review. Can J Cardiol. 2009;25(7):421–4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  54. Piga M, Cocco MC, Serra A, Boi F, Loy M, Mariotti S. The usefulness of 99mTc-sestaMIBI thyroid scan in the differential diagnosis and management of amiodarone-induced thyrotoxicosis. Eur J Endocrinol. 2008;159(4):423–9. https://doi.org/10.1530/EJE-08-0348.

    Article  CAS  PubMed  Google Scholar 

  55. Smith JR, Oates ME. Radionuclide imaging of the parathyroid glands: patterns, pearls, and pitfalls. Radiographics. 2004;24(4):1101–15. https://doi.org/10.1148/rg.244035718.

    Article  PubMed  Google Scholar 

  56. Johnson NA, Tublin ME, Ogilvie JB. Parathyroid imaging: technique and role in the preoperative evaluation of primary hyperparathyroidism. AJR Am J Roentgenol. 2007;188(6):1706–15. https://doi.org/10.2214/AJR.06.0938.

    Article  PubMed  Google Scholar 

  57. Eslamy HK, Ziessman HA. Parathyroid scintigraphy in patients with primary hyperparathyroidism: 99mTc sestamibi SPECT and SPECT/CT. Radiographics. 2008;28(5):1461–76. https://doi.org/10.1148/rg.285075055.

    Article  PubMed  Google Scholar 

  58. Clarke BL. Epidemiology of primary hyperparathyroidism. J Clin Densitom. 2013;16(1):8–13. https://doi.org/10.1016/j.jocd.2012.11.009.

    Article  PubMed  Google Scholar 

  59. Tezelman S, Shen W, Shaver JK, Siperstein AE, Duh QY, Klein H, Clark OH. Double parathyroid adenomas. Clinical and biochemical characteristics before and after parathyroidectomy. Ann Surg. 1993;218(3):300–7; discussion 307–309.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  60. Marcocci C, Cetani F. Clinical practice. Primary hyperparathyroidism. N Engl J Med. 2011;365(25):2389–97. https://doi.org/10.1056/NEJMcp1106636.

    Article  CAS  PubMed  Google Scholar 

  61. Rubin, M. R., Bilezikian, J. P., McMahon, D. J., Jacobs, T., Shane, E., Siris, E., . . . Silverberg, S. J. (2008). The natural history of primary hyperparathyroidism with or without parathyroid surgery after 15 years. J Clin Endocrinol Metab, 93(9), 3462–3470. https://doi.org/10.1210/jc.2007-1215.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  62. Bilezikian JP, Brandi ML, Eastell R, Silverberg SJ, Udelsman R, Marcocci C, Potts JT Jr. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the fourth international workshop. J Clin Endocrinol Metab. 2014;99(10):3561–9. https://doi.org/10.1210/jc.2014-1413.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  63. Wilhelm, S. M., Wang, T. S., Ruan, D. T., Lee, J. A., Asa, S. L., Duh, Q. Y., . . . Carty, S. E. (2016). The American Association of Endocrine Surgeons guidelines for definitive management of primary hyperparathyroidism. JAMA Surg, 151(10), 959–968. https://doi.org/10.1001/jamasurg.2016.2310.

    Article  PubMed  Google Scholar 

  64. Coakley A, Kettle A, Wells C, O'doherty M, Collins R. 99Tcm sestamibi-a new agent for parathyroid imaging. Nucl Med Commun. 1989;10(11):791–4.

    Article  CAS  PubMed  Google Scholar 

  65. Taillefer R, Boucher Y, Potvin C, Lambert R. Detection and localization of parathyroid adenomas in patients with hyperparathyroidism using a single radionuclide imaging procedure with technetium-99m-sestamibi (double-phase study). J Nucl Med. 1992;33(10):1801–7.

    CAS  PubMed  Google Scholar 

  66. Hindie E, Ugur O, Fuster D, O’Doherty M, Grassetto G, Urena P, et al. 2009 EANM parathyroid guidelines. Eur J Nucl Med Mol Imaging. 2009;36(7):1201–16. https://doi.org/10.1007/s00259-009-1131-z.

    Article  PubMed  Google Scholar 

  67. Pelletier-Galarneau M, Sogbein OO, Dinh L, Zuckier LS. Superiority of digital subtraction for analysis of simultaneously-acquired dual-radiopharmaceutical parathyroid scintigraphy. Open J Med Imaging. 2015;5(2):7. https://doi.org/10.4236/ojmi.2015.52007.

    Article  Google Scholar 

  68. Froberg AC, Valkema R, Bonjer HJ, Krenning EP. 99mTc-tetrofosmin or 99mTc-sestamibi for double-phase parathyroid scintigraphy? Eur J Nucl Med Mol Imaging. 2003;30(2):193–6. https://doi.org/10.1007/s00259-002-1030-z.

    Article  CAS  PubMed  Google Scholar 

  69. Caveny SA, Klingensmith WC III, Martin WE, Sage-El A, McIntyre RC Jr, Raeburn C, Wolfe P. Parathyroid imaging: the importance of dual-radiopharmaceutical simultaneous acquisition with 99mTc-sestamibi and 123I. J Nucl Med Technol. 2012;40(2):104–10. https://doi.org/10.2967/jnmt.111.098400.

    Article  PubMed  Google Scholar 

  70. Hindie E, Melliere D, Jeanguillaume C, Perlemuter L, Chehade F, Galle P. Parathyroid imaging using simultaneous double-window recording of technetium-99m-sestamibi and iodine-123. J Nucl Med. 1998;39(6):1100–5.

    CAS  PubMed  Google Scholar 

  71. Caixàs A, Bernà L, Piera J, Rigla M, Matías-Guiu X, Farrerons J, Puig-Domingo M. Utility of 99mTc-sestamibi scintigraphy as a first-line imaging procedure in the preoperative evaluation of hyperparathyroidism. Clin Endocrinol. 1995;43(5):525–30.

    Article  Google Scholar 

  72. Lavely, W. C., Goetze, S., Friedman, K. P., Leal, J. P., Zhang, Z., Garret-Mayer, E., . . . Ziessman, H. A. (2007). Comparison of SPECT/CT, SPECT, and planar imaging with single- and dual-phase (99m)Tc-sestamibi parathyroid scintigraphy. J Nucl Med, 48(7), 1084–1089. https://doi.org/10.2967/jnumed.107.040428.

    Article  PubMed  Google Scholar 

  73. O'Doherty MJ, Kettle AG, Wells P, Collins R, Coakley AJ. Parathyroid imaging with technetium-99m-sestamibi: preoperative localization and tissue uptake studies. J Nucl Med. 1992;33(3):313–8.

    CAS  PubMed  Google Scholar 

  74. Bénard F, Lefebvre B, Beuvon F, Langlois M-F, Bisson G. Rapid washout of technetium-99m-MIBI from a large parathyroid adenoma. J Nucl Med. 1995;36(2):241–3.

    PubMed  Google Scholar 

  75. Palestro CJ, Tomas MB, Tronco GG. Radionuclide imaging of the parathyroid glands. Semin Nucl Med. 2005;35(4):266–76. https://doi.org/10.1053/j.semnuclmed.2005.06.001.

    Article  PubMed  Google Scholar 

  76. Wimmer, G., Profanter, C., Kovacs, P., Sieb, M., Gabriel, M., Putzer, D., . . . Prommegger, R. (2010). CT-MIBI-SPECT image fusion predicts multiglandular disease in hyperparathyroidism. Langenbeck's Arch Surg, 395(1), 73–80. https://doi.org/10.1007/s00423-009-0545-1.

    Article  Google Scholar 

  77. Neumann DR, Obuchowski NA, Difilippo FP. Preoperative 123I/99mTc-sestamibi subtraction SPECT and SPECT/CT in primary hyperparathyroidism. J Nucl Med. 2008;49(12):2012–7. https://doi.org/10.2967/jnumed.108.054858.

    Article  PubMed  Google Scholar 

  78. Pelletier-Galarneau M, Sogbein B, Zuckier L. Coimaging of 123I-NaI can be eliminated from the scintigraphic evaluation of parathyroid adenoma with only minimal effect on final imaging diagnosis. J Nucl Med. 2013;54(Suppl 2):147.

    Google Scholar 

  79. Thomas DL, Bartel T, Menda Y, Howe J, Graham MM, Juweid ME. Single photon emission computed tomography (SPECT) should be routinely performed for the detection of parathyroid abnormalities utilizing technetium-99m sestamibi parathyroid scintigraphy. Clin Nucl Med. 2009;34(10):651–5. https://doi.org/10.1097/RLU.0b013e3181b591c9.

    Article  PubMed  Google Scholar 

  80. Jamal SA, Miller PD. Secondary and tertiary hyperparathyroidism. J Clin Densitom. 2013;16(1):64–8. https://doi.org/10.1016/j.jocd.2012.11.012.

    Article  PubMed  Google Scholar 

  81. Taïeb, D., Ureña-Torres, P., Zanotti-Fregonara, P., Rubello, D., Ferretti, A., Henter, I., . . . Blickman, J. G. (2013). Parathyroid scintigraphy in renal hyperparathyroidism: the added diagnostic value of SPECT and SPECT/CT. Clin Nucl Med, 38(8), 630.

    Article  PubMed  PubMed Central  Google Scholar 

  82. Lai EC, Ching AS, Leong HT. Secondary and tertiary hyperparathyroidism: role of preoperative localization. ANZ J Surg. 2007;77(10):880–2. https://doi.org/10.1111/j.1445-2197.2007.04264.x.

    Article  PubMed  Google Scholar 

  83. Loftus KA, Anderson S, Mulloy AL, Terris DJ. Value of sestamibi scans in tertiary hyperparathyroidism. Laryngoscope. 2007;117(12):2135–8. https://doi.org/10.1097/MLG.0b013e31813e602a.

    Article  PubMed  Google Scholar 

  84. Liddy S, Worsley D, Torreggiani W, Feeney J. Preoperative imaging in primary hyperparathyroidism: literature review and recommendations. Can Assoc Radiol J. 2017;68(1):47–55. https://doi.org/10.1016/j.carj.2016.07.004.

    Article  PubMed  Google Scholar 

  85. Kluijfhout, W. P., Pasternak, J. D., Drake, F. T., Beninato, T., Gosnell, J. E., Shen, W. T., . . . Suh, I. (2016). Use of PET tracers for parathyroid localization: a systematic review and meta-analysis. Langenbeck's Arch Surg, 401(7), 925–935. https://doi.org/10.1007/s00423-016-1425-0.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiology and Nuclear Medicine, Institut de Cardiologie de Montréal, Montréal, QC, Canada

    Matthieu Pelletier-Galarneau

  2. Department of Medical Imaging–Nuclear Medicine, Centre Hospitalier de l’Université de Montréal (CHUM), Montréal, QC, Canada

    Frédéric Arsenault

  3. Division of Nuclear Medicine, Department of Radiology, Montefiore Medical Center, Bronx, NY, USA

    Lionel S. Zuckier

  4. Albert Einstein College of Medicine, Bronx, NY, USA

    Lionel S. Zuckier

Authors
  1. Matthieu Pelletier-Galarneau
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Frédéric Arsenault
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Lionel S. Zuckier
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Matthieu Pelletier-Galarneau .

Editor information

Editors and Affiliations

  1. Department of Nuclear Medicine, Klinikum Westfalen - Knappschaftskrankenhaus Academic teaching hospital of the Ruhr University, Dortmund, Nordrhein-Westfalen, Germany

    Hojjat Ahmadzadehfar

  2. Department of Nuclear Medicine, Beta Klinik Bonn, Bonn, Germany

    Hans-Jürgen Biersack

  3. Division of Nuclear Medicine, Department of Radiology, Montefiore Medical Center, Bronx, NY, USA

    Leonard M. Freeman

  4. Albert Einstein College of Medicine, Bronx, NY, USA

    Lionel S. Zuckier

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Pelletier-Galarneau, M., Arsenault, F., Zuckier, L.S. (2020). Thyroid and Parathyroid Imaging. In: Ahmadzadehfar, H., Biersack, HJ., Freeman, L., Zuckier, L. (eds) Clinical Nuclear Medicine. Springer, Cham. https://doi.org/10.1007/978-3-030-39457-8_14

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-39457-8_14

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-39455-4

  • Online ISBN: 978-3-030-39457-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation